No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Power Knee Launches – World’s 1st Actively Powered Microprocessor Prosthetic Knee for Above-Knee Amputations

"Smart" Prosthesis Uses Advanced Algorithms to Detect Human Movementand Provide Real-Time, Active Powered Assistance

Editor: What To Know

  • The POWER KNEE delivers on that promise and represents an extraordinary milestone in mobility for people with limb loss and limb difference.
  • The POWER KNEE creates motion by providing active powered assistance while distinguishing whether its wearer is walking on varying surfaces, inclines, or declines, or sitting and standing.
  • Sigurdsson, the POWER KNEE’s motor-powered energy helps encourage more symmetrical motion and enhance its wearer’s endurance by helping them conserve their own energy, a consideration that can be especially critical for people with lower-limb loss or limb difference.

POWER KNEETM, the world’s first actively powered microprocessor prosthetic knee for people with above-knee amputation or limb difference reports Össur (Nasdaq: OSSR), a global innovation leader in the orthotics and prosthetics (O&P) industry with a rich history of pioneering breakthroughs.

POWER KNEE is groundbreaking bionic technology — a motor-powered “smart” prosthesis that uses advanced algorithms to detect human movement patterns, learns and adjusts to its wearer’s speed and cadence in real-time.

The POWER KNEE creates motion by providing active powered assistance while distinguishing whether its wearer is walking on varying surfaces, inclines, or declines, or sitting and standing. When ascending stairs, the wearer is able to perform a more natural “step-over-step” pattern, and experience more controlled resistance when descending stairs or ramps.

“No other knee thinks, acts or behaves remotely like the new, next-generation POWER KNEE,” said Jon Sigurdsson, President and CEO of Össur. “While other microprocessor knees are “passive” in nature, we have always considered the restoration of power – which is fundamental to the biomechanical systems that move all human bodies – to be a critical function that was lacking in other prosthetic solutions for amputees. The POWER KNEE delivers on that promise and represents an extraordinary milestone in mobility for people with limb loss and limb difference.”

According to Mr. Sigurdsson, the POWER KNEE’s motor-powered energy helps encourage more symmetrical motion and enhance its wearer’s endurance by helping them conserve their own energy, a consideration that can be especially critical for people with lower-limb loss or limb difference.

“For over 15 years, Össur has championed actively powered knee technology, continually expanding the boundary of what was possible in prosthetics because we saw the incredible potential for those with limb loss. The new POWER KNEE is a truly transformative solution that allows its users to accomplish things that were unimaginable before,” Mr. Sigurdsson said. “The era of powered prosthetics is here, and it will revolutionize what the world expects from a prosthesis.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy